03
Tue, Dec
29 New Articles

Schoenherr Advises EBG MedAustron on Expansion of MedAustron Cancer Treatment and Research Centre in Wiener Neustadt

Austria
Tools
Typography
  • Smaller Small Medium Big Bigger
  • Default Helvetica Segoe Georgia Times

Schoenherr has advised EBG MedAustron on the expansion of the MedAustron cancer treatment and research center in Wiener Neustadt. 

According to Schoenherr, this involved "obtaining the EIA permit for the addition of a new irradiation room (IR5 for short), which will be operated exclusively by a new particle accelerator. The approved extension is expected to enable the treatment of 1,200 patients per year. The aim is also to create additional treatment options for tumors that cannot be treated successfully at the moment and to make ion therapy accessible to a larger number of patients at the same time. The additional synchrocyclotron-based accelerator facility enables the increased use of carbon ions in addition to treatment with protons, thereby expanding the range of indications for tumors to be irradiated.”

In 2022, Schoenherr advised MedAustron on an EIA for its treatment room (as reported by CEE Legal Matters on May 24, 2022).

The Schoenherr team included Partner Christian Schmelz, Attorneys at Law Christoph Jirak and Sarah Wolf, and Associate Valentin Dignos.

Schoenherr at a Glance

Schoenherr is a leading full-service law firm providing local and international companies stellar advice that is straight to the point. With 15 offices and 4 country desks Schoenherr has a firm footprint in Central and Eastern Europe. Our lawyers are recognised leaders in their specialised areas and have a track record of getting deals done with a can-do, solution-oriented approach. Quality, flexibility, innovation and practical problem-solving in complex commercial mandates are at the core of our philosophy.

Firm's website: www.schoenherr.eu